Evidence map›Paper›PMID 37631027›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

The Potential of

Monaliza Teresa Campos Sodré, Fernanda Avelino Ferraz, Amanda Karoline Vieira Alencar, Karinny Farias Silva, Douglas Henrique Dos Santos Silva, Lucas Dos Santos Silva, Jéssica Silva Dos Santos Araújo Carneiro, Cristina Andrade Monteiro, Luis Cláudio Nascimento Silva, Andrea de Souza Monteiro

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Strategic antagonism: howFrontiers in microbiology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monaliza Teresa Campos SodréLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.
Fernanda Avelino FerrazLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.
Amanda Karoline Vieira AlencarLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.
Karinny Farias SilvaLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.
Douglas Henrique Dos Santos SilvaLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.ORCID 0000-0002-2669-1845
Lucas Dos Santos SilvaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.ORCID 0000-0002-7483-3238
Jéssica Silva Dos Santos Araújo CarneiroLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.
Cristina Andrade MonteiroLaboratory of Microbiology Research, Federal Institute of Education, Science and Technology of Maranhão (IFMA), São Luís 65030-005, MA, Brazil.ORCID 0000-0003-3082-1101
Luis Cláudio Nascimento SilvaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.ORCID 0000-0002-4206-0904
Andrea de Souza MonteiroLaboratory of Applied Microbiology, CEUMA University, São Luís 65075-120, MA, Brazil.

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 23038.000751/2021-37
6 · The paper itself

Abstract

This study aimed to evaluate the potential of lactic acid bacteria (LAB) in developing alginate-based gel formulations to inhibit

Indexed as

postbioticsprobioticsskin infectionsStaphylococcus aureustopical agents

Identifiers

PMID37631027
PMCPMC10458396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.